117 related articles for article (PubMed ID: 9469364)
1. Paternity in men with stage I testis tumors on surveillance.
Herr HW; Bar-Chama N; O'Sullivan M; Sogani PC
J Clin Oncol; 1998 Feb; 16(2):733-4. PubMed ID: 9469364
[TBL] [Abstract][Full Text] [Related]
2. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
[TBL] [Abstract][Full Text] [Related]
3. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.
Coogan CL; Hejase MJ; Wahle GR; Foster RS; Rowland RG; Bihrle R; Donohue JP
J Urol; 1996 Nov; 156(5):1656-8. PubMed ID: 8863564
[TBL] [Abstract][Full Text] [Related]
4. Paternity following treatment for testicular cancer.
Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O
J Natl Cancer Inst; 2005 Nov; 97(21):1580-8. PubMed ID: 16264178
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
6. Active surveillance after orchiectomy for nonseminomatous testicular germ cell tumors: late relapse may occur.
Boyer MJ; Cox K; Tattersall MH; Findlay MP; Grygiel J; Rogers J
Urology; 1997 Oct; 50(4):588-92. PubMed ID: 9338737
[TBL] [Abstract][Full Text] [Related]
7. Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection.
Hermans BP; Sweeney CJ; Foster RS; Einhorn LE; Donohue JP
J Urol; 2000 Jun; 163(6):1721-4. PubMed ID: 10799168
[TBL] [Abstract][Full Text] [Related]
8. Results of bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer.
Steiner H; Zangerl F; Stöhr B; Granig T; Ho H; Bartsch G; Peschel R
J Urol; 2008 Oct; 180(4):1348-52; discussion 1352-3. PubMed ID: 18707723
[TBL] [Abstract][Full Text] [Related]
9. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.
Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE
J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858
[TBL] [Abstract][Full Text] [Related]
10. Clinical stage I testis cancer: long-term outcome of patients on surveillance.
Sogani PC; Perrotti M; Herr HW; Fair WR; Thaler HT; Bosl G
J Urol; 1998 Mar; 159(3):855-8. PubMed ID: 9474168
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial.
Albers P; Siener R; Kliesch S; Weissbach L; Krege S; Sparwasser C; Schulze H; Heidenreich A; de Riese W; Loy V; Bierhoff E; Wittekind C; Fimmers R; Hartmann M;
J Clin Oncol; 2003 Apr; 21(8):1505-12. PubMed ID: 12697874
[TBL] [Abstract][Full Text] [Related]
12. Fertility status of patients with clinical stage I testis tumors on a surveillance protocol.
Carroll PR; Morse MJ; Whitmore WF; Sogani PC; Klotz L; Herr HW; Fair WR; Feldshuh R; Chaganti RS
J Urol; 1987 Jul; 138(1):70-2. PubMed ID: 3599224
[TBL] [Abstract][Full Text] [Related]
13. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
[TBL] [Abstract][Full Text] [Related]
14. Management of stage I nonseminomatous germ-cell tumors.
Thomas J; Aleman M; Dreicer R; Klein EA
Semin Urol Oncol; 2002 Nov; 20(4):220-6. PubMed ID: 12489053
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic and open retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testis tumors.
Abdel-Aziz KF; Anderson JK; Svatek R; Margulis V; Sagalowsky AI; Cadeddu JA
J Endourol; 2006 Sep; 20(9):627-31. PubMed ID: 16999613
[TBL] [Abstract][Full Text] [Related]
16. Fertility considerations in nerve-sparing retroperitoneal lymph-node dissection.
Foster RS; McNulty A; Rubin LR; Bennett R; Rowland RG; Sledge GW; Bihrle R; Donohue JP
World J Urol; 1994; 12(3):136-8. PubMed ID: 7951339
[TBL] [Abstract][Full Text] [Related]
17. [Management of stage I testicular nonseminomatous germ cell tumors with an embryonic carcinomatous component. 18 cases].
Drianno N; Robert M; Legouffe E; Guiter J; Navratil H
Prog Urol; 1997 Sep; 7(4):622-7. PubMed ID: 9410322
[TBL] [Abstract][Full Text] [Related]
18. Fatherhood in testicular cancer patients with carcinoma in situ in the contralateral testicle.
Jacobsen KD; Fosså SD
Eur Urol; 2000 Dec; 38(6):725-6;discussion 727. PubMed ID: 11111191
[TBL] [Abstract][Full Text] [Related]
19. Stage I nonseminomatous germ cell tumor of the testis: more questions than answers?
Powles T
Hematol Oncol Clin North Am; 2011 Jun; 25(3):517-27,viii. PubMed ID: 21570606
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in low-stage nonseminomatous testicular cancer.
Moul JW; Heidenreich A
Oncology (Williston Park); 1996 Sep; 10(9):1359-68, 1374; discussion 1377-8. PubMed ID: 8882926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
